Sustained HBsAg clearance among HBsAg positive recipients who received hematopoietic stem cells from donors with and without natural immunity to hepatitis B virus and preemptive nucleoside analog
. | Donor with natural immunity to HBV/preemptive nucleoside analog therapy, type . | . | . | . | . | ||||
|---|---|---|---|---|---|---|---|---|---|
. | Yes/lamivudine . | Yes/famciclovir . | Yes/no . | No/yes . | No/no . | ||||
| Durable HBsAg clearance | 11 | 4 | 4 | 0 | 0 | ||||
| No durable HBsAg clearance | 0* | 0† | 4*† | 0 | 0 | ||||